+9.5%
GSK vs BIDU
-38.7%
+48.2%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BIDU | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | +0.7% | -0.1% | +0.5% |
| 7D | +1.1% | -4.6% | +5.7% | +1.2% |
| 30D | +6.3% | -4.5% | +10.9% | +6.4% |
| 3M | +1.8% | -25.4% | +27.2% | +2.2% |
| 6M | +1.7% | -48.1% | +49.7% | +3.3% |
| YTD | +6.5% | -40.2% | +46.7% | +5.8% |
| 1Y | +9.5% | -35.2% | +44.7% | +8.3% |
| All | +9.5% | -38.7% | +48.2% | +8.3% |
Cumulative growth
Daily Returns
Daily percentage return beside BIDU.
Daily Out/Under-Performance
Portfolio return minus BIDU return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BIDU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BIDU wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling